Close

Flexion Therapeutics (FLXN) Announces Presentation of Statistically Significant Zilretta Phase 3 Data in OA of the Knee

Go back to Flexion Therapeutics (FLXN) Announces Presentation of Statistically Significant Zilretta Phase 3 Data in OA of the Knee